Vitamin B12 Corrects Genetic Disorder in Worms With Verheij Syndrome Mutation

Researchers have discovered that vitamin B12 supplementation can correct developmental defects in C. elegans worms modeling Verheij syndrome, a rare human genetic disorder.

The findings, reported by ScienceDaily, indicate that the vitamin can restore metabolic processes disrupted by the mutation, which is linked to impaired growth and developmental delays.

The study began when scientists investigating genes related to lifespan identified a mutation in a gene responsible for RNA splicing—a process where cells remove unnecessary portions of messenger RNA to prepare genetic instructions for protein production.

Because this gene is also associated with Verheij syndrome, the team used the roundworms to observe how the mutation impacted development. The worms carrying the mutation exhibited slowed growth and remained smaller than normal.

Analysis of the worms’ metabolism revealed that the mutation specifically disrupted pathways dependent on vitamin B12. When researchers provided the worms with additional vitamin B12, the treatment successfully restored these metabolic pathways and corrected the developmental abnormalities.

“We were surprised to find that a change in a fundamental process of RNA processing had such a targeted effect on vitamin B12-dependent metabolism,” said Jonathan Kölschbach, first author of the study.

“Even more exciting was that we were able to largely correct the consequences of this change in the worm model using vitamin B12,” said Jonathan Kölschbach.

To determine if these findings could translate to human health, the researchers analyzed human cell datasets and collected blood samples from patients with Verheij syndrome in collaboration with Hormos Dafsari, a neuropediatrician at the University Hospital Cologne.

The investigation uncovered evidence of similar metabolic changes in humans, suggesting that the vitamin B12-related pathways may be relevant to the human disorder. However, researchers said that it has not yet been established if vitamin B12 supplementation can improve symptoms in human patients, and further studies are required.

“Our study is a good example of how basic research on model organisms can provide new insights into human diseases,” said Adam Antebi, Director at the Max Planck Institute for Biology of Ageing and lead author of the study.

“A fundamental biological question can thus give rise to a new approach to therapy,” said Adam Antebi.

Photo of author

Priya Deshmukh - Senior Editor, Health

Priya Deshmukh Senior Editor, Health Deshmukh is a practicing physician and renowned medical journalist, honored for her investigative reporting on public health. She is dedicated to delivering accurate, evidence-based coverage on health, wellness, and medical innovations.

Kölner Haie Face Liberec in CHL Round of 16 Second Leg

Honoring Dolores Huerta: The Legacy of a Civil Rights Icon and the Power of Sí Se Puede